Hemophilia Investor Event
Sanofi a eu le plaisir de convier investisseurs et analystes à participer à notre Hemophilia Investor Event qui a eu lieu en personne à ExCel Londres le mercredi 13 juillet 2022. (2:00pm GMT / 15h00 CET / 9:00am EST)
Avec
![Dietmar Berger, MD PhD](/optim/dotcom/content-app/events/investor-presentation/2022/hemophilia-investor-event/DietmarB_20230405202911.jpg?size=small)
Dietmar Berger, MD PhD
Global Head of Development, CMO
![Bill Sibold](/optim/dotcom/content-app/events/investor-presentation/2022/hemophilia-investor-event/BillS_20230405202911.jpg?size=small)
Bill Sibold
Executive Vice President Specialty Care; President, Sanofi North America
![Guy Young, MD](/optim/dotcom/content-app/events/investor-presentation/2022/hemophilia-investor-event/GuyY_20230405202911.jpg?size=small)
Guy Young, MD
Director, Hemostasis and Thrombosis Center at Children's Hospital Los Angeles
![Angela Weyand, MD](/optim/dotcom/content-app/events/investor-presentation/2022/hemophilia-investor-event/AngelaW_20230405202911.jpg?size=small)
Angela Weyand, MD
Assistant Professor at Michigan Medicine